BI needed Pfizer.
whether the reps from Pfizer were productive, that's another story.
could sum it up to some were good, some not so good, mixed bag.
Bottom line is Pfizer Marketing is why Spiriva is where it is today.
BI's track record of marketing and launch is subpar. Marketing is more important than the product, and Pfiizer's success is monumental.
Wait until you see what Pfizer and BMS marketing have in store for Eliquis.
Nope. Pfizer doesn't bring shit. You clearly have no idea what you are talking about. Why don't you cruise on over the Pfizer's board to view the onslaught about ready to happen tomorrow for proof. Whn they have good drugs they do well (as they should) when the have marginal drugs they fall on their asses.
Explain the market share of :
Toviaz and Chantix and Pristiq or even Relpax?????? These drugs have yet to crack double digits market share and HENCE why they are laying off 40 percent of their card reps.
Lipitor - way better than zocor
Norvasc - way better than verapamil
Viagra - was great forever but really got taken by Cialis these last 4 years or so.
Celebrex - it's a good NSAID, preople swear by it.
Point is, they can't market shit any better than anyone else. If you have a good drug and some other incidentals (like no real competitor, 1st to market, etc) you will succeed. Every body sucks on Pfe's balls like they are awesome marketers, but if that were the case you wouldn't see them in the shitter with even shittier drug market shares. Use your brain, it's not just there to hold up your hair.
By the way, Eliquis has the best data set of all NEW Oral anticoags (if the books weren't cooked as I suspect they are). They wont be number 1 market share due to marketing efforts you dumb ass, it will be due to the drug itself.